Skip to main content Skip to secondary navigation

Publications

Main content start

2020

Assoumou SA, Nolen S, Hagan L, Wang J, Eftekhari Yazdi G, Thompson WW, Mayer KH, Puro J, Zhu L, Salomon JA, Linas BP. Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study. Am J Med 2020 (in press).

Assoumou SA, Tasillo A, Vellozzi C, Eftekhari Yazdi G, Wang J, Nolen S, Hagan L, Thompson W, Randall LM, Strick L, Salomon JA, Linas BP. Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons. Clin Infect Dis. 2020 Mar 17;70(7):1388-1396. 

Assoumou SA, Wang J, Nolen S, Eftekhari Yazdi G, Mayer KH, Puro J, Salomon JA, Linas BP. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic. J Gen Intern Med. 2020 May;35(5):1477-1483. 

Earnest R, Rönn MM, Bellerose M, Gift TL, Berruti AA, Hsu KK, Testa C, Zhu L, Malyuta Y, Menzies NA, Salomon JA. Population-level Benefits of Extragenital Gonorrhea Screening Among Men Who Have Sex With Men: An Exploratory Modeling Analysis. Sex Transm Dis. 2020 Jul;47(7):484-490. 

Marks SM, Dowdy DW, Menzies NA, Shete PB, Salomon JA, Parriott A, Shrestha S, Flood J, Hill AN. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination. Pub Health Rep 2020;135(1_suppl):38S-43S.

Menzies NA, Bellerose M, Testa C, Ssartwood N, Malyuta Y, Cohen T, Marks SM, Hill AN, Date AA, Maloney SA, Bowden SE, Grills AW, Salomon JA. Impact of effective global tuberculosis control on health and economic outcomes in the United States. Am J Respir Crit Care Med (in press).

Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay GR, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California. Am J Respir Crit Care Med. 2020; 201(3):356-365.

Rönn MM, Dunville R, Wang LY, Bellerose M, Malyuta Y, Menzies NA, Aslam M, Lewis F, Walker-Baban C, Asbel L, Parchem S, Masinter L, Perez E, Gift TL, Hsu K, Barrios LC, Salomon JA. Mathematical modeling study of school-based chlamydia screening: potential impact on chlamydia prevalence in intervention schools and surrounding communitiesBMC Public Health. 2020;20(1):1363.

Rönn MM, Menzies NA, Gift TL, Chesson HW, Trikalinos TA, Bellerose M, Malyuta Y, Berruti A, Gaydos CA, Hsu KK, Salomon JA. Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis. Clinical Infectious Diseases 2020; 70(9):1816-1823.

Rönn MM, Testa C, Tuite AR, Chesson HW, Gift TL, Schumacher C, Williford SL, Zhu L, Bellerose M, Earnest R, Malyuta Y, Hsu KK, Salomon JA, Menzies NA. The Potential Population-Level Impact of Different Gonorrhea Screening Strategies in Baltimore and San Francisco: An Exploratory Mathematical Modeling Analysis. Sex Transm Dis. 2020 Mar;47(3):143-150.

Yaesoubi R, Cohen T, Hsu K, Gift TL, Chesson H, Salomon JA, Grad YH. Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study. PLoS Med. 2020; 17(4):e1003077. 

Zhu L, Menzies NA, Wang J, Linas BP, Goodreau SM, Salomon JA. Estimation and correction of bias in network simulations based on respondent-driven sampling data. Sci Rep. 2020; 10(1):6348.  

2019

Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, et al. Hepatitis C Testing and Patient Characteristics in Washington State’s Prisons Between 2012 and 2016. Am J Prev Med 2019;56(1):8-16.

Bellerose M, Zhu L, Hagan LM, Thompson WW, Randall LM, Malyuta Y, Salomon JA, Linas BP. A review of network simulation models of hepatitis C virus and HIV among people who inject drugs. Int J Drug Policy 2019 Nov 15:102580. 

Epstein RL, Wang J, Hagan L, Mayer KH, Puro J, Linas BP, Assoumou SA. Hepatitis C Virus Antibody Testing Among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers. JAMA. 2019 Dec 10;322(22):2245-2248.

Rönn MM, Tuite AR, Menzies NA, Wolf EE, Gift TL, Chesson HW, et al. The Impact of Screening and Partner Notification on Chlamydia in the United States, 2000–2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model. American Journal of Epidemiology 2019; 188(3):545-554.

Tasillo A, Eftekhari Yazdi G, Nolen S, Schillie S, Vellozzi C, Epstein R, et al. Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care. Obstetrics & Gynecology 2019; 133(2):289-300. 

2018

Barocas JA, Tasillo A, Eftekhari Yazdi G, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Ward JW, Mermin J, Salomon JA, Linas BP. Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States. Clinical Infectious Diseases 2018: 67(4):549-556.

Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, et al. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J Pediatr 2018;203:34-40.

Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model. American Journal of Epidemiology 2018; 187(9):2011-2020.

Menzies NA, Hill AN, Cohen T, Salomon JA. The impact of migration on tuberculosis in the United StatesInt J Tuberculosis Lung Dis 2018; 22(12):1392-1403.

Menzies NA, Wolf E, Connors D, Bellerose M, Sbarra AN, Cohen T, Hill AN, Yaesoubi R, Galer K, White PJ, Abubakar I, Salomon JA. Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. The Lancet Infectious Diseases 2018; 18(8):e228-e238.

Menzies NA, Cohen T, Salomon JA. Evidence sources on the natural history of latent tuberculosis infection. The Lancet Infectious Diseases 2018; 18(8):834-835.

Neilan A, Dunville R, Ocfemia MC, Salomon J, Francke J, Wang LY, Bulteel A, Hsu K, DiNenno E, Parker R, Walensky R.Screening Adolescents and Young Adults for HIV in the United States: A Cost-Effectiveness Analysis. Journal of Adolescent HealthJournal of Adolescent Health. 2018 Jan;62(1):22-28.

Tuite AR, Rönn MM, Wolf EE, Gift TL, Chesson HW, Berruti A, Galer K, Menzies NA, Hsu K, Salomon JA. Estimated impact of screening on gonorrhea epidemiology in the United States: insights from a mathematical model. Sexually Transmitted Diseases 2018; 45(11):713-722.

2017

Barocas JA, Wang J, White LF, Tasillo A, Salomon JA, Freedberg KA, Linas BP. Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations. Health Affairs 2017;36(12):2142-2150.

Rönn MM, Wolf E, Chesson HW, Menzies NA, Galer K, Gorwitz R, Gift TL, Hsu K, Salomon JA. The use of mathematical models of chlamydia transmission to address public health policy questions: a systematic literature review. Sexually Transmitted Diseases. 2017, 44(5): 278-283. 

Tasillo A, Salomon JA, Trikalinos TA, Horsburgh CR, Marks SM, Linas BP. The cost-effectiveness of testing and treatment for latent tuberculosis infection in foreign-born US residents with and without medical comorbidities. JAMA Internal Medicine 2017; 177(12):1755-1764.

Tuite AR, Gift TL, Chesson HW, Hsu K, Salomon JA, Grad YH. Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea. The Journal of Infectious Diseases 2017; 216(9):1141-1149.